{"title":"Stem cell transplantation: Donors as research objects, the donor search process and beyond","authors":"S. Morsch","doi":"10.4172/2155-9864-c1-040","DOIUrl":"https://doi.org/10.4172/2155-9864-c1-040","url":null,"abstract":"","PeriodicalId":73627,"journal":{"name":"Journal of blood disorders & transfusion","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70322649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Heparin Induced Thrombocytopenia in a Patient with Antiphospholipid Syndrome","authors":"R. Ahmad, S. Chaudhry","doi":"10.4172/2155-9864.1000411","DOIUrl":"https://doi.org/10.4172/2155-9864.1000411","url":null,"abstract":"Heparin-induced thrombocytopenia (HIT) is a less commonly encountered adverse reaction of heparin characterized by formation of heparin complex with platelet factor 4 due to formation of autoantibody. HIT is reported in about 2% of all patients receiving heparin, out of which 35% develop thrombosis. In Antiphospholoipid syndrome autoantibodies are generated to phospholipid binding proteins which are risk factors for thrombosis and pregnancy complications. In this report we present case of a patient with recurrent venous thromboembolism receiving heparin and was found to develop HIT with coexistence of Antiphospholipid syndrome.","PeriodicalId":73627,"journal":{"name":"Journal of blood disorders & transfusion","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70322320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ali Ms, Begum Ba, Akhter S, N. K, Uddin Ukm, Akter S, Jolly Yn
{"title":"Evaluation of Blood Lead Level as a Risk Factor in Children with Autism Spectrum Disorder: A Case Control Study","authors":"Ali Ms, Begum Ba, Akhter S, N. K, Uddin Ukm, Akter S, Jolly Yn","doi":"10.4172/2155-9864.1000415","DOIUrl":"https://doi.org/10.4172/2155-9864.1000415","url":null,"abstract":"The present study deals with the Evaluation of Blood lead (Pb) level as a risk factor in Autistic Children and to determine the association between blood lead level (BLL) and Autism Spectrum Disorder (ASD). It was a casecontrol study. Blood samples were collected from both case (25 of 3-16 years) and control (25 of 3-16 years) groups by vein puncture for the determination of blood lead levels using Energy Dispersive X-ray Fluorescence (EDXRF) technique. Predesigned questionnaires were completed for each case and control group by interviewing the parents or care-givers. The present study revealed that there was a significant difference between mean ages of mother at child’s birth in both case and control group. Significantly more children in case group had parents with higher educational levels and came from families with higher socioeconomic status. Significantly more children in ASD group came from urban areas than rural area. The risk of exposure to air pollution in case group was 14 times more than the control group which is represented by the proximity of child’s residence to high traffic roads. History of pica was exclusively present in case group (p value 0.001) indicating that children in ASD group had more exposure to lead than those of control group. The mean blood levels were 44.18 and 29.22 μg/dl for case and control group respectively. In case group 48% of the children had blood lead level ≥ 10 μg/dl compared to 24% in the control group.","PeriodicalId":73627,"journal":{"name":"Journal of blood disorders & transfusion","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70322889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lugos, Okoh Jb, Polit Uy, V. Ny, Ofojekwu Mjn, Nnanna Ou, Damen Jg, Iheanacho Cu, Ntuhun Bd, Damulak Od
{"title":"Some Hematologic Parameters of Blood Donors at the National Blood Transfusion Service (NBTS), Jos, Nigeria","authors":"Lugos, Okoh Jb, Polit Uy, V. Ny, Ofojekwu Mjn, Nnanna Ou, Damen Jg, Iheanacho Cu, Ntuhun Bd, Damulak Od","doi":"10.4172/2155-9864.1000416","DOIUrl":"https://doi.org/10.4172/2155-9864.1000416","url":null,"abstract":"Introduction: A blood donor is expected to be a healthy individual who donates his or her blood for the medical treatment of patients. World Health Organisation (WHO) recommends that only those with good health status should be accepted as blood donors. Full blood count is a standard haematology test that evaluates a blood sample for a variety of basic parameters and partly applicable in the general screening of health. Normal haemoglobin level is one of the requirements for blood donor suitability. Normal haemoglobin alone does not connote normalcy of other haematologic variables. The full blood count of blood donors may reveal other blood measurements that may contribute to the better assessment of donors and standardisation of blood donor selection.Aim: This research is aimed to evaluate some haematological parameters of assumingly healthy volunteer blood donors at the NBTS (National Blood Transfusion Service), in Jos, Plateau State.Methods: A total of 102 potential healthy blood donors from Jos City and Du Village participated in the study. We obtained 2.5 ml of venous blood aseptically from each donor into an EDTA container and mixed. The full blood counts of the samples were all analysed. The values gotten were subjected to statistical analysis using the SPSS version 23 software.Results: The packed cell volume (PCV), total and differential white blood cell counts and platelet count were significantly different compared to local reference ranges. Further, evaluation of the parameters between genders, locations, age groups and occupations of donors, the platelet, PCV and eosinophil counts differed significantly (p=0.042, 0.00 and 0.029 respectively). The average white blood cells (WBC) count was lower among donors in the rural area (p=0.000).Conclusion: There may be a significant number of apparently healthy blood donors with abnormal haematologic parameters. Full blood count should be included in evaluating blood donors to ensure blood and donor safety.","PeriodicalId":73627,"journal":{"name":"Journal of blood disorders & transfusion","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70322516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Prevalence/Incidence of Hereditary and Acquired Thrombophilia Markers among Egyptian Females with Recurrent Pregnancy Loss or IVF Failure","authors":"A. V., Issa H, R. A","doi":"10.4172/2155-9864.1000412","DOIUrl":"https://doi.org/10.4172/2155-9864.1000412","url":null,"abstract":"","PeriodicalId":73627,"journal":{"name":"Journal of blood disorders & transfusion","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70322608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
P. Kumari, M. Mangalagowri, Kavitha Bl, C. ObulaReddy, S. Shanthala, M. Mahadavaprasad, Madhumathi Ds, Govinda Bk
{"title":"A Rare Presentation of ph Chromosome: idic der (22q11) in Blast Crisis Chronic Myeloid Leukemia","authors":"P. Kumari, M. Mangalagowri, Kavitha Bl, C. ObulaReddy, S. Shanthala, M. Mahadavaprasad, Madhumathi Ds, Govinda Bk","doi":"10.4172/2155-9864.1000414","DOIUrl":"https://doi.org/10.4172/2155-9864.1000414","url":null,"abstract":"The ider(22)t(9;22)(q34;q11) is a rare secondary karyotypic abnormality of Ph chromosome positive chronic myeloid leukemia associated with disease progression, poor clinical outcome and short survival in most of the previously reported cases. The present case of CML with idic der(22)t(9;22)(q34;q11) or idic der Ph with hybrid transcript ratio of BCR-ABL being 97% showed a complex karyotype: 48,XY,+8,t(9;22)(q34;q11)i dic(22)(q11),+idic der(22)t(9;22)(q34;q11). On treatment with Imatinib the initial transcript ratio was reduced to 12.125%, 0.932% but later increased to 93%. The patient developed extra medullary myeloid cell tumor of testis after a year of treatment followed by the detection of T3151 mutation. Cytogenetics provides an evidence for progression of disease at an earlier phase than other markers in this case.","PeriodicalId":73627,"journal":{"name":"Journal of blood disorders & transfusion","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70322811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"CALR and CD47: An Insight into Their Roles in the Disease Progression of MDS and MPN","authors":"K. Boasman, M. Simmonds, C. Rinaldi","doi":"10.4172/2155-9864.1000413","DOIUrl":"https://doi.org/10.4172/2155-9864.1000413","url":null,"abstract":"Myelodysplastic syndrome and myeloproliferative neoplasms are clonal myeloid disorders arising from haematopoietic stem cells that have the tendency to progress into acute myeloid leukaemia. Multiple prognostic scoring systems have been proposed and utilised in clinical practice to predict disease evolution, however none of them can predict treatment response. In solid tumours, the relationship between the pro-phagocytic calreticulin and the anti-phagocytic CD47 is repeatedly investigated. Overexpression of calreticulin has been documented to produce a pro-phagocytic signal in solid tumour and it is often counteracted by a concomitant expression of the anti-phagocytic CD47 as they act in response to one another, reflecting an apoptosis vs survival mechanism in response to chemotherapy. The role of both calreticulin and CD47 are currently poorly understood in myeloid malignancies including myelodysplastic syndrome and myeloproliferative neoplasms. The aim of this review is to elaborate on the current understanding round the roles and implications of calreticulin and CD47 signalling with in solid and haematological cancers, discuss potential roles for calreticulin and CD47 expression in transformation of myeloid cells in patients with MDS or MPN into AML and how these advances are starting to be used to design new therapeutic strategies to determine disease progression and treatment response in both solid cancer and myeloid malignancies.","PeriodicalId":73627,"journal":{"name":"Journal of blood disorders & transfusion","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49285544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Keri Csencsits-Smith, Krill Grushin, Svetla Stoilova-McPhie
{"title":"Binding of Factor VIII to Lipid Nanodiscs Increases its Clotting Function in a Mouse Model of Hemophilia A.","authors":"Keri Csencsits-Smith, Krill Grushin, Svetla Stoilova-McPhie","doi":"10.4172/2155-9864.1000325","DOIUrl":"https://doi.org/10.4172/2155-9864.1000325","url":null,"abstract":"<p><strong>Background: </strong>Hemophilia A is a congenital bleeding disorder caused by defective or deficient factor VIII (FVIII). The active form of FVIII is the co-factor for the serine protease factor IXa (FIXa) in the membrane-bound intrinsic tenase (FVIIIa-FIXa) complex. The assembly of the FVIIIa-FIXa complex on the activated platelet surface is critical for successful blood clotting.</p><p><strong>Objectives: </strong>To characterize the role of lipid nanodiscs (ND) for on FVIII function in vivo and test the lipid ND as a delivery system for FVIII. To evaluate the potential of binding recombinant FVIII to ND as improved treatment for Hemophilia A.</p><p><strong>Methods: </strong>Recombinant porcine FVIII (rpFVIII) was expressed and characterized in solution, and when bound to ND. The rpFVIII, ND and rpFVIII-ND complexes were characterized via transmission electron microscopy. Functional studies were carried out using aPTT tests and time resolved tail snip studies of hemophilic mice.</p><p><strong>Results: </strong>Functional rpFVIII was successfully assembled on lipid ND. When injected in hemophilic mice, the rpFVIII-ND complexes showed a pronounced pro-coagulant effect, which was stronger than that of rpFVIII alone. While injection of the ND alone showed a pro-coagulant effect this effect was not additive, implying that the rpFVIII-ND complexes have a synergistic effect on the clotting process in hemophilic mice.</p><p><strong>Conclusions: </strong>Binding of rpFVIII to ND prior to its injection in hemophilic mice significantly improves the therapeutic function of the protein. This represents a meaningful step towards a new approach to modulate blood coagulation at the membrane-bound FVIII level and the assembly of the intrinsic tenase complex.</p>","PeriodicalId":73627,"journal":{"name":"Journal of blood disorders & transfusion","volume":"6 6","pages":"325"},"PeriodicalIF":0.0,"publicationDate":"2015-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4172/2155-9864.1000325","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9340245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Benjamin M. Looney, Anna V. Chernatynskaya, M. Clare-Salzler, C. Xia
{"title":"Characterization of Bone Marrow-Derived Dendritic Cells Developed in Serum-Free Media and their Ability to Prevent Type 1 Diabetes in Nonobese Diabetic Mice","authors":"Benjamin M. Looney, Anna V. Chernatynskaya, M. Clare-Salzler, C. Xia","doi":"10.4172/2155-9864.1000206","DOIUrl":"https://doi.org/10.4172/2155-9864.1000206","url":null,"abstract":"Dendritic cells (DC) have been investigated as a cell-based therapy for Type 1 Diabetes (T1D). BM-DC expanded ex vivo with GM-CSF and IL-4 is typically cultured with fetal bovine serum (FBS). The effect of FBS on NOD BM-DC has not been extensively studied. In the present study we compare BM-DC generated in serum-free culture media (X-VIVO20; FBS−) with BM-DC generated in media containing 10% FBS (RPMI1640/10%FBS; FBS+). We show that FBS− BM-DC display a phenotype and cytokine-producing profile distinct from FBS+ BMDC. Additionally, compared to FBS+ BM-DC, we show evidence of an altered Th cell response induced by FBS− BM-DC. Finally, we demonstrate that only FBS− BM-DC prevent the onset of T1D and induce increased levels of CD4+Foxp3+ regulatory T cells as well as a long-lasting β cell-specific T cell response. This study indicates that serum-free media generates a more tolerogenic BM-DC capable of preventing T1D in the NOD mice.","PeriodicalId":73627,"journal":{"name":"Journal of blood disorders & transfusion","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2014-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4172/2155-9864.1000206","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70322220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}